Fisher Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Fisher Asset Management’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,764	Closed	-$265K	–	859
2018 Q2	$265K	Sell	15,764 -59,075	-79%	-$1.15M	﹤0.01%	724
2018 Q1	$1.71M	Hold	74,839	–	–	﹤0.01%	529
2017 Q4	$1.94M	Hold	74,839	–	–	﹤0.01%	520
2017 Q3	$1.1M	Hold	74,839	–	–	﹤0.01%	555
2017 Q2	$1.04M	Buy	74,839 +30,476	+69%	+$449K	﹤0.01%	533
2017 Q1	$757K	Buy	44,363 +8,200	+23%	+$98.3K	﹤0.01%	526
2016 Q4	$372K	Hold	36,163	–	–	﹤0.01%	597
2016 Q3	$366K	Sell	36,163 -19,771	-35%	-$216K	﹤0.01%	607
2016 Q2	$669K	Hold	55,934	–	–	﹤0.01%	539
2016 Q1	$759K	Hold	55,934	–	–	﹤0.01%	536
2015 Q4	$1.06M	Hold	55,934	–	–	﹤0.01%	506
2015 Q3	$1.05M	Buy	+55,934	New	+$951K	﹤0.01%	488

Other funds holding CNCE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fisher Asset Management's CNCE Position: Q3 2018 in Review

Fisher Asset Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2018, closing a stake of 15,764 shares — an estimated $265K sold.

Fisher Asset Management first reported a position in CNCE in Q3 2015 and held it in 12 quarters. The position peaked at $1.94M in Q4 2017. 111 funds tracked by Wall St. Rank hold CNCE as of Q3 2018.

Fisher Asset Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Fisher Asset Management sold 15,764 Concert Pharmaceuticals, Inc. shares in Q3 2018, an estimated $265K.
Fisher Asset Management first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 12 quarters.
Fisher Asset Management's Concert Pharmaceuticals, Inc. position peaked at $1.94M in Q4 2017.
111 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2018.

Based on Fisher Asset Management's 13F filing for Q3 2018, filed 24 Oct 2018.